Position in ACHV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$588,000
-$480,038 QoQ
Shares Held
200,000
-6.9% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#20
of 81 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $316,393,134 across 63 Biotechnology names. ACHV ranks #52 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | ANAB |
Anaptysbio, Inc
|
625,000 | $34,662,500 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
775,000 | $11,206,500 |
All Filings in ACHV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $588,000 | 200,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,068,038 | 214,897 | Shares | Defined | 2026-02-17 | |
| 2022-09-30 | $412,500 | 125,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $610,000 | 125,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $946,250 | 125,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $972,500 | 125,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,062,500 | 125,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,122,500 | 125,000 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||